Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aclarion, Inc. stock logo
ACON
Aclarion
$0.28
-1.2%
$0.32
$0.27
$25.60
$2.01M0.42.72 million shs120,608 shs
CannLabs, Inc. stock logo
CANL
CannLabs
$0.00
$0.00
$0.01
$1.04M1.45200 shsN/A
Vyant Bio, Inc. stock logo
VYNT
Vyant Bio
$0.19
+7.8%
$0.19
$0.14
$1.58
$1.23M1.73161,822 shs19,100 shs
Zicix Co. stock logo
ZICX
Zicix
$0.00
$0.00
$0.00
$0.00
$550K0.85113,822 shsN/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aclarion, Inc. stock logo
ACON
Aclarion
+2.78%-0.39%-8.59%-84.63%-97.51%
CannLabs, Inc. stock logo
CANL
CannLabs
0.00%0.00%0.00%+1,000.00%-87.50%
Vyant Bio, Inc. stock logo
VYNT
Vyant Bio
0.00%0.00%0.00%0.00%-25.38%
Zicix Co. stock logo
ZICX
Zicix
0.00%0.00%-0.33%-33.33%-25.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aclarion, Inc. stock logo
ACON
Aclarion
N/AN/AN/AN/AN/AN/AN/AN/A
CannLabs, Inc. stock logo
CANL
CannLabs
N/AN/AN/AN/AN/AN/AN/AN/A
Vyant Bio, Inc. stock logo
VYNT
Vyant Bio
N/AN/AN/AN/AN/AN/AN/AN/A
Zicix Co. stock logo
ZICX
Zicix
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aclarion, Inc. stock logo
ACON
Aclarion
N/AN/AN/AN/A
CannLabs, Inc. stock logo
CANL
CannLabs
N/AN/AN/AN/A
Vyant Bio, Inc. stock logo
VYNT
Vyant Bio
N/AN/AN/AN/A
Zicix Co. stock logo
ZICX
Zicix
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aclarion, Inc. stock logo
ACON
Aclarion
$80K25.11N/AN/A($0.38) per share-0.74
CannLabs, Inc. stock logo
CANL
CannLabs
N/AN/AN/AN/AN/AN/A
Vyant Bio, Inc. stock logo
VYNT
Vyant Bio
$670K1.83N/AN/A$1.69 per share0.11
Zicix Co. stock logo
ZICX
Zicix
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aclarion, Inc. stock logo
ACON
Aclarion
-$4.91MN/A0.00N/A-6,480.47%-724.93%-249.67%7/1/2024 (Estimated)
CannLabs, Inc. stock logo
CANL
CannLabs
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Vyant Bio, Inc. stock logo
VYNT
Vyant Bio
-$22.69MN/A0.00N/A-3,474.81%-151.82%-97.14%N/A
Zicix Co. stock logo
ZICX
Zicix
N/AN/A0.00N/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aclarion, Inc. stock logo
ACON
Aclarion
N/AN/AN/AN/AN/A
CannLabs, Inc. stock logo
CANL
CannLabs
N/AN/AN/AN/AN/A
Vyant Bio, Inc. stock logo
VYNT
Vyant Bio
N/AN/AN/AN/AN/A
Zicix Co. stock logo
ZICX
Zicix
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aclarion, Inc. stock logo
ACON
Aclarion
N/A
0.40
0.40
CannLabs, Inc. stock logo
CANL
CannLabs
N/AN/AN/A
Vyant Bio, Inc. stock logo
VYNT
Vyant Bio
0.04
2.86
2.86
Zicix Co. stock logo
ZICX
Zicix
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Aclarion, Inc. stock logo
ACON
Aclarion
7.52%
CannLabs, Inc. stock logo
CANL
CannLabs
N/A
Vyant Bio, Inc. stock logo
VYNT
Vyant Bio
N/A
Zicix Co. stock logo
ZICX
Zicix
N/A

Insider Ownership

CompanyInsider Ownership
Aclarion, Inc. stock logo
ACON
Aclarion
22.30%
CannLabs, Inc. stock logo
CANL
CannLabs
N/A
Vyant Bio, Inc. stock logo
VYNT
Vyant Bio
9.56%
Zicix Co. stock logo
ZICX
Zicix
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Aclarion, Inc. stock logo
ACON
Aclarion
47.15 million5.56 millionNot Optionable
CannLabs, Inc. stock logo
CANL
CannLabs
37942.16 millionN/ANot Optionable
Vyant Bio, Inc. stock logo
VYNT
Vyant Bio
46.33 million5.72 millionNot Optionable
Zicix Co. stock logo
ZICX
Zicix
2916.02 millionN/ANot Optionable

VYNT, CANL, ZICX, and ACON Headlines

Recent News About These Companies

Best art supplies stores to shop online in the UK
ZICIX+CTIP-FII UPDATES STOCKHOLDERS ON PROJECTS ON-GOING
ZICIX Finalizes Acquisition of CTIP-FII

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Aclarion logo

Aclarion

NASDAQ:ACON
Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.
CannLabs logo

CannLabs

OTCMKTS:CANL
CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services. CannLabs, Inc. was incorporated in 2010 and is based in Denver, Colorado.
Vyant Bio logo

Vyant Bio

OTCMKTS:VYNT
Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD). The company is based in Cherry Hill, New Jersey.
Zicix logo

Zicix

OTCMKTS:ZICX
Zicix Corporation, through its subsidiary, Texas Mobile Health, Inc., provides diagnostic medical imaging services in Houston, Texas. It offers cardiac diagnostic services, including echocardiogram, stress testing, carotid ultrasound, and halter and event monitoring services; medical services, such as general medical care, medical care for home health patients, general and immigration physicals, weight reduction, cold laser pain relief treatment, physical therapy, and anti-aging treatment; and MRI, CT, and X-Ray services. The company was formerly known as Bederra Corporation and changed its name to Zicix Corporation on February 8, 2011. Zicix Corporation was founded in 1979 and is based in Houston, Texas.